(VIANEWS) – SEMAPA (SEM.LS), FRONTLINE (FRO.OL), VISTIN PHARMA (VISTN.OL) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| SEMAPA (SEM.LS) | 20.62% | 2024-05-03 08:23:48 |
| FRONTLINE (FRO.OL) | 10.59% | 2024-05-03 08:26:03 |
| VISTIN PHARMA (VISTN.OL) | 7.92% | 2024-05-03 08:44:11 |
| BANK OF IRELAND GP (BIRG.IR) | 5.93% | 2024-05-03 08:22:14 |
| ALPES (COMPAGNIE) (CDA.PA) | 5.88% | 2024-05-03 08:45:25 |
| ALTRI SGPS (ALTR.LS) | 5.26% | 2024-05-03 08:22:53 |
| BOIRON (BOI.PA) | 4% | 2024-04-28 11:45:24 |
| ABL GROUP (ABL.OL) | 3.76% | 2024-05-03 08:24:06 |
| JACQUES BOGART (JBOG.PA) | 2.68% | 2024-04-28 11:49:50 |
| MERCK AND CO INC (MRK.PA) | 2.61% | 2024-04-28 08:00:07 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. SEMAPA (SEM.LS)
20.62% Foward Dividend Yield
SEMAPA’s last close was €15.80, 3.95% higher than its 52-week high of €15.20. Intraday change was -0.13%.
Semapa – Sociedade de Investimento e Gestão, SGPS, S.A., through its subsidiaries, produces and sells uncoated woodfree (UWF) printing and writing paper. It operates through three segments: Pulp and Paper, Cement and Derivatives, and Environment. The company offers pulp and tissue paper; researches, develops, produces, and sells forestry and agricultural products; produces and sells bleached eucalyptus kraft pulp (BEKP), cork, and pine wood products; and produces and sells energy from thermal, natural gas, and biofuel sources. It is also involved in the production and sale of cement, ready-mixed concrete, aggregates, mortars, prefabricated concrete structures, hydraulic lime, and clinker products; and operation of quarries. In addition, the company offers environment related services comprising collection, packaging, sorting, unpacking, upgrading, recovery, and sale of animal by-products and food products containing animal origin substances for the production of fertilizers and animal feed, and oil products for the biodiesel market. It has operations in Portugal, rest of Europe, the United States, Africa, Asia, and Oceania. The company was incorporated in 1991 and is headquartered in Lisbon, Portugal.
Earnings Per Share
As for profitability, SEMAPA has a trailing twelve months EPS of €3.04.
PE Ratio
SEMAPA has a trailing twelve months price to earnings ratio of 5.19. Meaning, the purchaser of the share is investing €5.19 for every euro of annual earnings.
More news about SEMAPA.
2. FRONTLINE (FRO.OL)
10.59% Foward Dividend Yield
FRONTLINE’s last close was kr266.00, 29.44% higher than its 52-week high of kr205.50. Intraday change was 1.2%.
Frontline plc, a shipping company, engages in the seaborne transportation of crude oil and oil products worldwide. It owns and operates oil and product tankers. As of December 31, 2023, the company operated a fleet of 76 vessels. It is also involved in the charter, purchase, and sale of vessels. The company was founded in 1985 and is based in Limassol, Cyprus.
Earnings Per Share
As for profitability, FRONTLINE has a trailing twelve months EPS of kr32.8.
PE Ratio
FRONTLINE has a trailing twelve months price to earnings ratio of 8.21. Meaning, the purchaser of the share is investing kr8.21 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.1%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, FRONTLINE’s stock is considered to be oversold (<=20).
More news about FRONTLINE.
3. VISTIN PHARMA (VISTN.OL)
7.92% Foward Dividend Yield
VISTIN PHARMA’s last close was kr23.40, 6.77% under its 52-week high of kr25.10. Intraday change was 0%.
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.27.
PE Ratio
VISTIN PHARMA has a trailing twelve months price to earnings ratio of 18.43. Meaning, the purchaser of the share is investing kr18.43 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.31%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.2%, now sitting on 438.33M for the twelve trailing months.
Sales Growth
VISTIN PHARMA’s sales growth is 10.6% for the current quarter and 6.6% for the next.
More news about VISTIN PHARMA.
4. BANK OF IRELAND GP (BIRG.IR)
5.93% Foward Dividend Yield
BANK OF IRELAND GP’s last close was €10.32, 1.43% below its 52-week high of €10.47. Intraday change was -0.44%.
Bank of Ireland Group plc provides various banking and financial products and services. It provides current and savings accounts, and business deposits and accounts; personal, car, home improvement, graduate, motor finance, and student loans, as well as overdrafts; and business and farming loans, green business, insurance premium finance, invoice finance, hire purchase, and leasing services. The company also offers international payments and credit cards; protection overview, mortgage protection, life cover, specified illness cover, income protection, protection for individuals, and protection for families; pensions; investments; foreign exchange, treasury services, leveraged acquisition and property finance services; personal products; and premier and private banking services. In addition, it provides home, car, travel, and life insurance products. The company was founded in 1783 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, BANK OF IRELAND GP has a trailing twelve months EPS of €1.41.
PE Ratio
BANK OF IRELAND GP has a trailing twelve months price to earnings ratio of 7.29. Meaning, the purchaser of the share is investing €7.29 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.3%.
Volume
Today’s last reported volume for BANK OF IRELAND GP is 1762370 which is 39.73% below its average volume of 2924140.
Yearly Top and Bottom Value
BANK OF IRELAND GP’s stock is valued at €10.28 at 22:50 EST, under its 52-week high of €10.47 and way higher than its 52-week low of €7.73.
Volatility
BANK OF IRELAND GP’s last week, last month’s, and last quarter’s current intraday variation average was 0.66%, 0.35%, and 1.77%.
BANK OF IRELAND GP’s highest amplitude of average volatility was 1.13% (last week), 1.48% (last month), and 1.77% (last quarter).
Moving Average
BANK OF IRELAND GP’s worth is way above its 50-day moving average of €9.20 and way higher than its 200-day moving average of €8.88.
More news about BANK OF IRELAND GP.
5. ALPES (COMPAGNIE) (CDA.PA)
5.88% Foward Dividend Yield
ALPES (COMPAGNIE)’s last close was €13.70, 11.61% under its 52-week high of €15.50. Intraday change was 1.75%.
Compagnie des Alpes SA, together with its subsidiaries, engages in the operation of leisure facilities in France. The company operates through Ski Areas and Leisure Parks segments. The Ski Areas segment operates ski lifts; and maintains slopes. This segment also operates ski resorts. The Leisure Parks segment is involved in the operation of amusement parks, combined amusement and animal parks, water parks, waxwork museums, and tourist sites. Compagnie des Alpes SA was founded in 1989 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, ALPES (COMPAGNIE) has a trailing twelve months EPS of €1.78.
PE Ratio
ALPES (COMPAGNIE) has a trailing twelve months price to earnings ratio of 7.83. Meaning, the purchaser of the share is investing €7.83 for every euro of annual earnings.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.1%, now sitting on 1.13B for the twelve trailing months.
More news about ALPES (COMPAGNIE).
6. ALTRI SGPS (ALTR.LS)
5.26% Foward Dividend Yield
ALTRI SGPS’s last close was €5.15, 5.1% higher than its 52-week high of €4.90. Intraday change was 0.19%.
Altri, SGPS, S.A. produces and sells cellulosic fibers and energy in Portugal and internationally. The company produces pulp products for various application including production of paper, tissue, and printing and writing papers; and dissolving pulp for use of textile production. It is also involved timber commercialization; forest management; production of forest-based renewable energy, such as industrial cogeneration from black liquor and biomass; real estate activities; and production of plants in nurseries, as well as the provision of services related with forests and landscapes. The company was incorporated in 2005 and is headquartered in Porto, Portugal.
Earnings Per Share
As for profitability, ALTRI SGPS has a trailing twelve months EPS of €0.21.
PE Ratio
ALTRI SGPS has a trailing twelve months price to earnings ratio of 24.57. Meaning, the purchaser of the share is investing €24.57 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.9%.
Sales Growth
ALTRI SGPS’s sales growth is negative 29.3% for the present quarter and 244% for the next.
Moving Average
ALTRI SGPS’s value is way higher than its 50-day moving average of €4.51 and way above its 200-day moving average of €4.45.
More news about ALTRI SGPS.
7. BOIRON (BOI.PA)
4% Foward Dividend Yield
BOIRON’s last close was €34.05, 39.73% under its 52-week high of €56.50. Intraday change was 1.02%.
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Earnings Per Share
As for profitability, BOIRON has a trailing twelve months EPS of €2.74.
PE Ratio
BOIRON has a trailing twelve months price to earnings ratio of 12.27. Meaning, the purchaser of the share is investing €12.27 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.64%.
More news about BOIRON.
8. ABL GROUP (ABL.OL)
3.76% Foward Dividend Yield
ABL GROUP’s last close was kr11.40, 38.38% under its 52-week high of kr18.50. Intraday change was 1.75%.
ABL Group ASA, an investment holding company, provides energy, and marine and engineering consultancy services to renewables, maritime, and oil and gas industries worldwide. It offers technical and due diligence; owner's engineering; project development; geotechnical and geophysical; HSEQ and risk consulting; marine operations and engineering; marine design, upgrade, and conversion; site investigations; clean shipping; engineering and design, jack-up and installation vessel support; advanced analysis and simulation; digital; subsea cables; and client reps and secondment services. The company provides asset management, maintenance, inventory, and data optimization solutions; marine surveys, inspections, and audits, including vessel and marine assurance, rig inspections, industry standard audit, vessel condition surveys, pre-purchase survey, and dynamic positioning, as well as marine warranty survey services. In addition, it offers marine casualty management comprising marine salvage and wreck removal consultancy, hull and machinery claims, and P&I claims services; and expert witness and litigation support services. Further, the company provides software solutions, such as EFFIO, a cloud-based data build and optimization software for asset management strategy; ePAV, a data collection, audit, and verification software; emiTr, an emissions tracking software, as well as AssetVoice. The company was formerly known as AqualisBraemar LOC ASA and changed its name to ABL Group ASA in June 2022. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.
Earnings Per Share
As for profitability, ABL GROUP has a trailing twelve months EPS of kr0.78.
PE Ratio
ABL GROUP has a trailing twelve months price to earnings ratio of 14.87. Meaning, the purchaser of the share is investing kr14.87 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.53%.
More news about ABL GROUP.
9. JACQUES BOGART (JBOG.PA)
2.68% Foward Dividend Yield
JACQUES BOGART’s last close was €7.10, 12.13% below its 52-week high of €8.08. Intraday change was 8.06%.
Jacques Bogart S.A. produces and sells fragrances and cosmetics in Paris and internationally. The company markets its fragrance products under the JACQUES BOGART, CARVEN, CHEVIGNON, and TED LAPIDUS brand names; cosmetic products under the STENDHAL, METHODE JEANNE PIAUBERT, and APRIL brand names; and fashion products under the TED LAPIDUS FASHION brand name. Jacques Bogart S.A. was founded in 1975 and is based in Paris, France.
Earnings Per Share
As for profitability, JACQUES BOGART has a trailing twelve months EPS of €-0.61.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.87%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5%, now sitting on 298.63M for the twelve trailing months.
Volatility
JACQUES BOGART’s last week, last month’s, and last quarter’s current intraday variation average was 2.79%, 0.16%, and 2.16%.
JACQUES BOGART’s highest amplitude of average volatility was 2.79% (last week), 2.26% (last month), and 2.16% (last quarter).
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jul 5, 2023, the estimated forward annual dividend rate is 0.18 and the estimated forward annual dividend yield is 2.68%.
Moving Average
JACQUES BOGART’s value is above its 50-day moving average of €6.55 and below its 200-day moving average of €6.80.
More news about JACQUES BOGART.
10. MERCK AND CO INC (MRK.PA)
2.61% Foward Dividend Yield
MERCK AND CO INC’s last close was €101.40, 7.82% under its 52-week high of €110.00. Intraday change was 0%.
Earnings Per Share
As for profitability, MERCK AND CO INC has a trailing twelve months EPS of €4.82.
PE Ratio
MERCK AND CO INC has a trailing twelve months price to earnings ratio of 21.04. Meaning, the purchaser of the share is investing €21.04 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.69%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 14, 2023, the estimated forward annual dividend rate is 2.7 and the estimated forward annual dividend yield is 2.61%.
More news about MERCK AND CO INC.
